Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise

NCT03353350 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: efpeglenatide (SAR439977)
DRUG: placebo

Sponsor

Hanmi Pharmaceutical Company Limited

Collaborators

[object Object]